Zepsun (donafenib) - Suzhou Zelgen
AiTan (rivoceranib) - Elevar Therapeutics
Tecentriq (atezolizumab) - Roche
sorafenib - Generic mfg.
Lenvima (lenvatinib) - Eisai, Merck (MSD)
Avastin (bevacizumab) - Roche
Keytruda (pembrolizumab) - Merck (MSD)
Focus V (anlotinib) - Advenchen
Tevimbra (tislelizumab-jsgr) - BeOne Medicines
AiRuiKa (camrelizumab) - Elevar Therapeutics
Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Bioscience, Coherus Oncology
Tyvyt (sintilimab) - Innovent Biologics, Eli Lilly
http://www.ncbi.nlm.nih.gov/pubmed/42703316
 
Jia-Ye Long; Shang-Ren Huang; Xin-Hong Wang; Yan Luo; Yong-Run Li; Zhi-Jian Li
 
Sep 8, 2026
 
Prev Next